Carbapenem Market Size, Trends, Growth, Opportunities (2022-2030) | Spero Therapeutics, Inc., Savior Lifetec Corporation, Meiji Seika Pharma Co., Ltd.

The market is being driven by an increase in infectious diseases like urinary tract infections (UTIs), intra-abdominal infections, and bacterial meningitis. Based on product type analysis, in 2021, the other segments accounted for the largest market share. By region, during the projection period, Asia Pacific is anticipated to witness the fastest growth.

𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐀𝐝𝐝𝐫𝐞𝐬𝐬𝐞𝐬:
• The global carbapenem market was valued at USD 3.90 billion in 2021 and is projected to grow to USD 5.7 billion by 2030.
• The market is anticipated to exhibit a CAGR of 4.5% during the forecast period.
• The market is mainly segmented on the basis of product type, sales channel, and region.
• North America leads the global carbapenem market.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/carbapenem-market/request-for-sample

𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
Carbapenem refers to a class of strong antibiotics used to treat severe or high-risk bacterial infections. They are highly effective in combatting a diverse array of bacteria, including many that are resistant to various antibiotics. Carbapenems work by inhibiting the production of bacterial cell walls, leading to the death of the bacteria. Meropenem, imipenem, and ertapenem are commonly utilized carbapenems. Due to their potency, they are usually reserved for serious infections or those caused by bacteria resistant to many medications.

𝐌𝐚𝐣𝐨𝐫 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
In this extremely competitive market, major rivals constantly innovate and differentiate their products in an effort to take the lead in the market.

The report has covered the major players operating in the Carbapenem market:
• Spero Therapeutics, Inc.,
• Savior Lifetec Corporation,
• Meiji Seika Pharma Co., Ltd.,
• Merck & Co., Inc.,
• Gland Pharma Ltd. (Fosun Pharmaceutical Co., Ltd.),
• Aurobindo Pharma Ltd.,
• Daewoong Pharmaceutical Co., Ltd.,
• Iterum Therapeutics plc,
• ACS Dobfar S.p.A.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞: https://www.polarismarketresearch.com/industry-analysis/carbapenem-market/request-for-discount-pricing

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:
Because the patent for carbapenem-based antibiotics has expired, generic medicine producers can now enter the market with their cost-effective medications. Generic medicine manufacturers aim to widen the market for their products. Furthermore, the increasing number of generic competitors in the market is speeding up the creation of generic drugs. Multiple Asian companies are currently in the process of developing active pharmaceutical ingredients (API) essential for producing generic carbapenem-based antibiotics.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐲𝐩𝐞
• Meropenem
• Imipenem
• Doripenem
• Tebipenem
• Others

𝐁𝐲 𝐒𝐚𝐥𝐞𝐬 𝐂𝐡𝐚𝐧𝐧𝐞𝐥
• Hospital Pharmacies
• Retail Pharmacies & Drug Stores
• Online Pharmacies

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞: https://www.polarismarketresearch.com/industry-analysis/carbapenem-market/inquire-before-buying

𝐂𝐚𝐫𝐛𝐚𝐩𝐞𝐧𝐞𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬:
• Hospital held the largest segment in the sales channel segment with rising infections and adaptation of generic treatments.
• North America held the dominant position because of high prescription rate of antibiotics and advancements in research and development leading to the emergence and launch of new medicines.
• The global market is highly competitive owing to the existence of large market players with a global presence, including Spero Therapeutics, Inc., Savior Lifetec Corporation, Meiji Seika Pharma Co., Ltd., Merck & Co., Inc., Gland Pharma Ltd. (Fosun Pharmaceutical Co., Ltd.), Aurobindo Pharma Ltd., Daewoong Pharmaceutical Co., Ltd., Iterum Therapeutics plc, ACS Dobfar S.P.A.

𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭:
𝐒𝐆𝐋𝐓𝟐 𝐈𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/sglt2-inhibitors-market

𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/medical-automation-market

𝐕𝐞𝐭𝐞𝐫𝐢𝐧𝐚𝐫𝐲 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐏𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/veterinary-surgical-procedures-market

𝐌𝐚𝐠𝐧𝐞𝐭𝐢𝐜 𝐁𝐞𝐚𝐝𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/magnetic-beads-market

𝐂𝐨𝐥𝐥𝐚𝐠𝐞𝐧 𝐀𝐧𝐝 𝐆𝐞𝐥𝐚𝐭𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/collagen-gelatin-regenerative-medicine-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.